CureWave Lasers LLC

CureWave Lasers manufactures high-intensity laser therapy (HILT) systems designed for non-invasive treatment of acute and chronic pain, soft tissue injuries, and difficult-to-treat orthopedic conditions. The CureWave Laser System is an infrared photobiomodulation device that operates at wavelengths exceeding 1280 nm, optimizing penetration depth while minimizing absorption by melanin, hemoglobin, and oxyhemoglobin. The system delivers photonic energy to injured and inflamed tissues, with claimed mechanisms including stimulation of cell growth, increased vascular activity, anti-inflammatory action, enhanced metabolic activity, improved nerve function, pain reduction, scar tissue reduction, and accelerated rehabilitation. Treatment sessions typically range from 15–30 minutes, with recommended initial frequency of three sessions per week adjusted based on patient progress. The device is marketed to medical practitioners, physical therapy clinics, sports medicine facilities, and athletic training centers as an alternative to pharmaceutical pain management and surgical intervention. The system is described as non-invasive with no reported adverse reactions or allergies, leveraging the body's natural healing processes. CureWave positions the technology as suitable for spinal stenosis, acute injuries, chronic pain conditions, and soft tissue healing applications. The company emphasizes clinical outcomes, practitioner return on investment, and patient satisfaction improvements. No specific FDA clearance, 510(k), ISO, or other regulatory certifications are explicitly mentioned in available content.